In those studies, FTIs were found to block aberrant nuclear morphology and improve phenotypes in tissue culture cells expressing progerin, in HGPS patient cells, and in HGPS mouse models [35–42]. The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.